GCMI would like to extend our congratulations to Ethos Medical for winning first place in the final round of Georgia Tech’s 11th annual InVenture Prize competition. Ethos Medical (previously Neuraline) aims to improve patient outcomes for procedures like spinal taps and epidurals with their ultrasound-based needle guidance system that alerts the anesthesiologist when the needle is in the proper location for drug delivery.
From Atlanta’s leading startup publication Hypepotamus:
One of the last presenters, Ethos Medical, ultimately took home the First Place designation for their ultrasound-based needle guidance system for procedures such as spinal taps and epidurals. The team landed $20,000, a free patent filing from Georgia Tech’s Office of Technology Licensing, and automatic acceptance into the next cohort of Create-X’s Startup Launch Program.
The final round consisted of three-minute pitches from the six finalist startup teams, and a four-minute Q&A session with the panel of expert judges. You can read the full article in Hypepotamus.
Last year, GCMI featured Ethos Medical on our website as they performed their first-ever preclinical session with a practicing anesthesiologist in our T3 Labs facility. “Is one young Georgia Tech company about to end complications from epidural misplacement?”
Every year, we offer promising biomedical engineering students from Georgia Tech access to the facilities and resources needed to advance their medtech projects.
“We are grateful to T3 Labs for providing access to the facilities and resources the team needed to be ready for our first ever preclinical session with a practicing anesthesiologist,” said Cassidy Wang, co-founder of [Ethos]. “There we acquired the customer feedback and functional performance data needed to keep us moving forward efficiently on the complex pathway from concept to commercialization.”
Ethos Medical will now move on to compete in the inaugural Georgia InVenture Prize (a project of the Georgia Chamber of Commerce) on April 4 and the ACC InVenture Prize Competition on April 17.
GCMI is proud to give innovators the support and guidance they need to advance their medtech projects on the complex pathway from concept to commercialization. Contact us today to learn more about our accelerator program, design and development services and preclinical CRO facilities.